Company Overview and News

 
Law firms clamour to profit from Commonwealth Bank's behaviour

2018-04-10 theage.com.au
The Commonwealth Bank has found itself in the middle of a battlefield between two class action laws firms and their respective litigation funding partners.
Upvote Downvote

 
Law firms clamour to profit from Commonwealth Bank's behaviour

2018-04-10 smh.com.au
The Commonwealth Bank has found itself in the middle of a battlefield between two class action laws firms and their respective litigation funding partners.
Upvote Downvote

 
Australia’s biggest bank rejects fresh laundering claims

2018-02-23 themalaymailonline
The logo of the Commonwealth Bank of Australia (CBA) is displayed outside a branch in Sydney, Australia March 21, 2016. — Reuters picSYDNEY, Feb 23 — Australia's largest bank the Commonwealth today denied a slew of new claims by the country's financial intelligence agency that it breached anti-money laundering laws, and rejected a major class action over the allegations.
Upvote Downvote

 
US tax joy, commodity lift kicks off ASX Santa rally

2017-12-19 theage.com.au
Investors flooded into shares on Tuesday, buoyed by new record highs on Wall Street and a broad-based lift in commodity prices. 
Upvote Downvote

 
US tax joy, commodity lift kicks off ASX Santa rally

2017-12-19 smh.com.au
Investors flooded into shares on Tuesday, buoyed by new record highs on Wall Street and a broad-based lift in commodity prices. 
Upvote Downvote

1
IMF to bankroll Santanol fight

2017-11-13 businessnews.com.au
The private investors in sandalwood business Santanol Group, led by Tony Jack and Bob Bunning, have gained backing from litigation funder IMF Bentham for their fight against private equity group KKR.
Upvote Downvote

 
Silent Partners: The bankrollers behind the rush of Australia shareholder lawsuits

2017-10-18 in.reuters
SYDNEY (Reuters) - After Australian internet company Vocus Telecommunications Ltd gave its second profit warning in seven months, fund manager David Pace received an email from a law firm asking him to join a shareholder class action.
Upvote Downvote

 
Silent Partners: The bankrollers behind the rush of Australia shareholder lawsuits

2017-10-18 reuters
SYDNEY (Reuters) - After Australian internet company Vocus Telecommunications Ltd (VOC.AX) gave its second profit warning in seven months, fund manager David Pace received an email from a law firm asking him to join a shareholder class action.
Upvote Downvote

 
MOVES-Bentham IMF appoints head of new bankruptcy unit

2017-10-16 reuters
Oct 16 (Reuters) - Bentham IMF, the U.S. arm of litigation funding company IMF Bentham Limited, has hired Ken Epstein to head its new bankruptcy unit, which will provide funding for insolvency disputes.
Upvote Downvote

 
Who's who in firing line in CBA class action

2017-10-09 theage.com.au
It's being billed as the largest shareholder class action in Australian history. It remains to be seen whether this boast comes to pass but the class action litigation against the Commonwealth Bank will certainly involve a lot of shareholders.
Upvote Downvote

 
Who's who in firing line in CBA class action

2017-10-09 smh.com.au
It's being billed as the largest shareholder class action in Australian history. It remains to be seen whether this boast comes to pass but the class action litigation against the Commonwealth Bank will certainly involve a lot of shareholders.
Upvote Downvote

 
CBA shareholders launch class action over money-laundering scandal

2017-10-09 abc.net.au
A massive class action potentially worth "hundreds of millions of dollars" has been launched against the Commonwealth Bank (CBA) for a drop in its share price following accusations it breached anti-money-laundering and terrorism finance laws.
Upvote Downvote

 
Court proceedings issued against CBA

2017-10-09 businessnews.com.au
Federal Court proceedings have been issued in the shareholder class action against Commonwealth Bank of Australia, which is being funded by Perth-based IMF Bentham.
Upvote Downvote

 
Commonwealth Bank of Australia hit with class action suit over money-laundering rule breaches

2017-10-09 themalaymailonline
CBA has not disputed that it processed tens of thousands of illicit transfers but argues the breaches were largely caused by a software glitch and contests its level of responsibility. — Reuters pic
Upvote Downvote

 
CommBank hit with class action

2017-10-09 perthnow.com.au
Law firm Maurice Blackburn on Monday said a statement of claim filed in the Federal Court in Victoria names outgoing chief executive Ian Narev and current chair Catherine Livingstone as being among those who knew CBA had been accused of breaching anti-money laundering and counter-terrorism funding laws.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...